Abacus FCF Advisors’s Biogen BIIB Stock Holding History

Abacus FCF Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,499	Closed	-$818K	–	97
2019 Q2	$818K	Sell	3,499 -390	-10%	-$90.1K	0.67%	95
2019 Q1	$919K	Buy	+3,889	New	+$1.22M	0.71%	95
2017 Q1	–	Sell	-185	Closed	-$52K	–	103
2016 Q4	$52K	Buy	+185	New	+$54.8K	0.87%	87
2016 Q1	–	Sell	-7,752	Closed	-$2.38M	–	105
2015 Q4	$2.38M	Buy	+7,752	New	+$2.23M	1.09%	17
2015 Q2	–	Sell	-4,960	Closed	-$2.09M	–	99
2015 Q1	$2.09M	Sell	4,960 -356	-7%	-$140K	1.03%	90
2014 Q4	$1.8M	Buy	+5,316	New	+$1.72M	1.11%	23

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Abacus FCF Advisors's BIIB Position: Q3 2019 in Review

Abacus FCF Advisors sold out of Biogen (BIIB) in Q3 2019, closing a stake of 3,499 shares — an estimated $818K sold.

Abacus FCF Advisors first reported a position in BIIB in Q4 2014 and held it in 6 quarters. The position peaked at $2.38M in Q4 2015. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Abacus FCF Advisors reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Abacus FCF Advisors sold 3,499 Biogen shares in Q3 2019, an estimated $818K.
Abacus FCF Advisors first reported a position in Biogen in Q4 2014 and held it in 6 quarters.
Abacus FCF Advisors's Biogen position peaked at $2.38M in Q4 2015.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Abacus FCF Advisors's 13F filing for Q3 2019, filed 9 Oct 2019.